关闭×

    Use our advanced search tool to find the exact model you need.

    Model Search  
    Labroots-LAS-2021-主页-395-290

    实验动物科学2021
    由LabRoots主持

    Join us February 10 to learn about recent advances in drug discovery and development.

    了解更多
    商业人士团体

    Career opportunities at Envigo

    If you would like to become part of the team that shapes our future, then visit our careers portal for our current vacancies.

    事业Portal  
    产品指南主页子网站功能

    Envigo’s 2020 product guide

    让我们帮助您实现您独特的研究目标。访问我们的2020-2021产品指南,探索我们扩展的研究模式和服务。

    立即下载

    Latest events

    最新消息

    Scientific insights

    SfN Global Connectome
    B0B体育平台下载恩维戈很高兴参加首次
    LabRoots Laboratory Animal Sciences 2021
    February 10, 2021 6AM PST This is a premier online-only conference that will bring together scientists from basic sciences to bioinformatics, clinicians, veterinary technicians, veterinarians, technical suppo...
    毒理学学会| 2021年毒理学展览会
    2021年3月12日至26日毒理学专家和科学家将参加一年一度的毒理学博览会,交流业界领先的理念和最佳实践。通过现场、半现场和点播服务,与会者将。。。
    All latest events  
    B0B体育平台下载Envigo将从Horizon收购研究模型业务部门
    Allows Envigo, a leading supplier of standard research models, to offer transgenic research models and associated services to its global customer base Horizon transgenic model generation and contract breeding expertis...
    LabCorp和EnviB0B体育平台下载go完成创新交易
    LabCorp收购了Envigo的B0B体育平台下载全球非临床合同研究业务,Envigo收购了LabCorp的Covance研究产品业务北卡罗来纳州伯灵顿市和印第安纳波利斯市——2019年6月3日——LabCorp®(NYSE:LH),。。。
    LabCorp和EnviB0B体育平台下载go签署了创新协议,以扩大科文斯的非临床药物开发能力,并创建一个独立的研究模型提供商
    LabCorp will purchase Envigo’s nonclinical contract research services business, expanding the global reach and capabilities of Covance’s nonclinical drug development business Envigo’s research models...
    All latest news  
    White paper

    蛲虫在实验动物研究中的负面影响

    蛲虫是利用实验室小鼠和老鼠进行研究的一种阴险而常见的威胁。这种有害生物会对研究结果的重现性和可靠性产生不利影响。此外,蛲虫引起的寄生负荷和副作用在免疫缺陷动物身上更为明显。

    案例研究

    罐头盒™ 纽扣延长了啮齿类动物的导管通畅

    希望同时提高3Rs和导管通畅度?罐头盒™ 按钮会有帮助。这种创新的封闭系统提高了动物和技术人员的福利,同时增加了导管的通畅性。

    White paper

    R2G2®小鼠的PDX、CDX和同种异体移植物生长

    三个最近的研究明确表示:R2G2®备忘录e is well suited for preclinical cancer studies that generate PDX, CDX and allograft models. The R2G2® mouse exhibited reduced radiosensitivity compared to NSGTM mice and tolerated estrogen supplementation and three standard-of-care chemotherapy drugs reasonably well. Moreover, as compared to other traditionally used immunodeficient strains, the R2G2® mouse had higher take rates and more favorable tumor growth.

    All Scientific Insights